Technical Analysis for SNY - Sanofi

Grade Last Price % Change Price Change
A 54.4 2.53% 1.34
SNY closed up 2.53 percent on Friday, May 20, 2022, on 88 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Gapped Up Strength 0.00%
Crossed Above 20 DMA Bullish 2.53%
Crossed Above 50 DMA Bullish 2.53%
MACD Bullish Signal Line Cross Bullish 2.53%
Gapped Up Strength 2.53%
20 DMA Resistance Bearish 3.84%
50 DMA Resistance Bearish 3.84%
Bearish Engulfing Bearish 3.84%
Evening Star Bearish 3.84%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.84%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 17 hours ago
Gapped Up (Full) about 19 hours ago
Rose Above Previous Day's High about 19 hours ago
Up 2% about 19 hours ago
Up 1% about 19 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sanofi Description

Sanofi researches, develops, manufactures, and markets healthcare products worldwide. The company operates through Pharmaceuticals, Human Vaccines, and Animal Health segments. Its principal products include Lantus and Apidra analogs of human insulin; Insuman, a range of human insulin solutions and suspensions; Amaryl, an oral once-daily sulfonylurea; BGStar and iBGStar blood glucose meters; enzyme replacement therapies, such as Cerezyme for Gaucher disease, Fabrazyme for Fabry, and Myozyme/Lumizyme for Pompe disease; Aubagio, an oral immunomodulator for multiple sclerosis; Taxotere, a taxane derivative for various cancer types; Eloxatine for colorectal cancer; and Jevtana for prostate cancer. The company's products also consist of thrombosis medicines, such as Plavix anti-platelet agent for atherothrombotic conditions and Lovenox to prevent and treat deep vein thrombosis; and cardiovascular medicines include Multaq anti-arrhythmic agent and Aprovel/CoAprovel for hypertension treatments. It also offers Renagel/Renvela oral phosphate binders used in patients with chronic kidney disease on dialysis to treat high phosphorus levels; Synvisc and Synvisc-One viscosupplements to treat pain associated with osteoarthritis of certain joints; and pediatric and influenza, adult and adolescent booster, meningitis and pneumonia, and travel and endemics vaccines. In addition, the company provides pharmaceuticals and vaccines used by veterinarians, farmers, and pet owners; consumer health care products to treat fever, pain, and digestive health areas; and generic medicines. Sanofi distributes its products through its sales force, as well as through physicians, pharmacies, hospitals, distributors, veterinaries, chemists, and wholesalers. It has alliance arrangements with Bristol-Myers Squibb, Regeneron, and Warner Chilcott. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1970 and is headquartered in Paris, France.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Cancer Life Sciences Pharmaceutical Health Sciences Pain Prostate Cancer Phosphates Hypertension Animal Health Influenza Kidney Disease Multiple Sclerosis Dialysis Glucose Colorectal Cancer Insulin Suspension Healthcare Products Chronic Kidney Disease Osteoarthritis Health Care Products Veins Cac 40 Fever Hepatotoxins Platelet Pneumonia Thrombosis Meningitis Phosphorus Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Gaucher Disease Pompe Disease Regeneron Clopidogrel Enzyme Replacement Therapies Glucose Meter

Is SNY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 58.1
52 Week Low 46.925
Average Volume 2,102,476
200-Day Moving Average 51.05
50-Day Moving Average 53.03
20-Day Moving Average 52.68
10-Day Moving Average 52.24
Average True Range 1.15
RSI 57.63
ADX 13.58
+DI 28.82
-DI 19.21
Chandelier Exit (Long, 3 ATRs) 52.78
Chandelier Exit (Short, 3 ATRs) 54.10
Upper Bollinger Bands 55.04
Lower Bollinger Band 50.33
Percent B (%b) 0.86
BandWidth 8.94
MACD Line -0.15
MACD Signal Line -0.34
MACD Histogram 0.1931
Fundamentals Value
Market Cap 136.55 Billion
Num Shares 2.51 Billion
EPS 1.94
Price-to-Earnings (P/E) Ratio 28.04
Price-to-Sales 2.83
Price-to-Book 1.68
PEG Ratio 3.24
Dividend 1.70
Dividend Yield 3.13%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 55.58
Resistance 3 (R3) 55.50 55.03 55.38
Resistance 2 (R2) 55.03 54.73 55.07 55.32
Resistance 1 (R1) 54.72 54.55 54.88 54.79 55.25
Pivot Point 54.25 54.25 54.33 54.29 54.25
Support 1 (S1) 53.93 53.95 54.09 54.01 53.55
Support 2 (S2) 53.46 53.76 53.50 53.48
Support 3 (S3) 53.15 53.46 53.42
Support 4 (S4) 53.22